Immunovia AB (publ)
STO:IMMNOV

Watchlist Manager
Immunovia AB (publ) Logo
Immunovia AB (publ)
STO:IMMNOV
Watchlist
Price: 0.189 SEK -3.57% Market Closed
Market Cap: kr127.1m

Wall Street
Price Targets

IMMNOV Price Targets Summary
Immunovia AB (publ)

Wall Street analysts forecast IMMNOV stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMMNOV is 0.49 SEK with a low forecast of 0.485 SEK and a high forecast of 0.504 SEK.

Lowest
Price Target
0.485 SEK
157% Upside
Average
Price Target
0.49 SEK
159% Upside
Highest
Price Target
0.504 SEK
167% Upside
Immunovia AB (publ) Competitors:
Price Targets
CAMT
Camtek Ltd
13% Upside
ATC
Arctic Paper SA
46% Upside
HZO
MarineMax Inc
22% Upside
ZIP
Ziprecruiter Inc
53% Upside
PXS
Pyxis Tankers Inc
132% Upside

Revenue
Forecast

6% / Year
Past Growth
330% / Year
Estimated Growth
Estimates Accuracy
-98%
Average Miss
6% / Year
Past Growth
330% / Year
Estimated Growth
Estimates Accuracy
-98%
Average Miss

For the last 11 years the compound annual growth rate for Immunovia AB (publ)'s revenue is 6%. The projected CAGR for the next 3 years is 330%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMMNOV's stock price target?
Price Target
0.49 SEK

According to Wall Street analysts, the average 1-year price target for IMMNOV is 0.49 SEK with a low forecast of 0.485 SEK and a high forecast of 0.504 SEK.

What is Immunovia AB (publ)'s Revenue forecast?
Projected CAGR
330%

For the last 11 years the compound annual growth rate for Immunovia AB (publ)'s revenue is 6%. The projected CAGR for the next 3 years is 330%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett